|
1 Year Recurrence After Modified en Bloc Resection (ERBT) vs Transurethral Resection (TURBT) for Large Bladder Tumors
RECRUITINGPhase 3Sponsored by dmitry enikeev
Actively Recruiting
PhasePhase 3
Sponsordmitry enikeev
Started2026-06-08
Est. completion2027-06-08
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07898033
Summary
to compare pathological and oncological outcomes of TURBT versus ERBT in patients with bladder tumors sizes \>2.5cm.
Eligibility
Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria: * Patients aged ≥18 years with * Bladder tumor \>2.5cm measured on US\\CT\\MRI (suspected non-muscle invasive bladder cancer). * Performance status (ECOG) ≤2. * Signed informed consent form to participate in the study Exclusion Criteria: * Multifocal tumors (≥4 lesions). * Prior history of BCG unresponsive bladder cancer. * Prior systemic chemotherapy or immunotherapy for any malignancy. * UTUC. * Evidence of metastatic disease. * Contraindications for endoscopic surgery for bladder tumor. * Benign bladder tumor on postoperative pathology.
Conditions3
CancerNMIBCTCC
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhasePhase 3
Sponsordmitry enikeev
Started2026-06-08
Est. completion2027-06-08
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07898033